Macquarie Group LTD Rhythm Pharmaceuticals, Inc. Transaction History

Macquarie Group LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$4.3 - $30.85 $9,300 - $66,728	-2,163 Reduced 26.52%	5,992 $200,000
Q4 2021 Feb 11, 2022	BUY	$8.62 - $13.9 $3,999 - $6,449	464 Added 6.03%	8,155 $81,000
Q3 2021 Nov 12, 2021	BUY	$11.68 - $20.72 $67,288 - $119,367	5,761 Added 298.5%	7,691 $100,000
Q2 2021 Aug 13, 2021	BUY	$18.52 - $22.55 $27,094 - $32,990	1,463 Added 313.28%	1,930 $38,000
Q1 2021 May 14, 2021	SELL	$20.25 - $39.49 $4,495 - $8,766	-222 Reduced 32.22%	467 $10,000
Q2 2020 Aug 11, 2020	BUY	$14.41 - $25.35 $9,928 - $17,466	689 New	689 $15,000
Q1 2018 May 11, 2018	SELL	$19.9 - $32.25 $5,970 - $9,675	-300 Closed	0 $0
Q4 2017 Feb 15, 2018	BUY	$22.0 - $30.51 $6,600 - $9,153	300	300 $9,000

192

67.3M

834K

78.6K

Ticker RYTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,720,000
Market Cap $3.34B
Description
Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

Stay updated on Macquarie Group LTD with notifications on news.